pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jul 29·1 min read
save

AI startup Doctronic acquires text-message pediatric care provider Summer Health

Jul 29, 2026·read at Endpoints ↗DealNeutral

Doctronic, a startup that markets itself as an AI doctor, announced it has purchased Summer Health, a company that offers pediatric care via text messaging.

The acquisition expands Doctronic’s services into the children’s health market, adding a platform that lets parents communicate with clinicians through SMS.

The deal is described as the first of several expected moves as Doctronic seeks to broaden its AI-driven healthcare offerings.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “AI doctor Doctronic buys Summer Health, expanding into pediatric care”

read at Endpoints ↗
81 words · retrieved Jul 29
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 7h agoAnthropic buys a single-person biotech startup backed by Atlas VentureEndpoints
  • 9h agoBacked by Amish and Mennonites, a new kind of gene therapy company takes shapeEndpoints
  • 11h agoDraft COINS rules could threaten broad China collaborationsEndpoints
  • 11h agoLilly's ads can continue after Novo challenge, judge rulesEndpoints
  • 14h agoGubra looks beyond metabolism, hopes for first portfolio company this yearEndpoints